218 related articles for article (PubMed ID: 10200332)
1. Fumonisin B1 induces apoptosis in cultured human keratinocytes through sphinganine accumulation and ceramide depletion.
Tolleson WH; Couch LH; Melchior WB; Jenkins GR; Muskhelishvili M; Muskhelishvili L; McGarrity LJ; Domon O; Morris SM; Howard PC
Int J Oncol; 1999 May; 14(5):833-43. PubMed ID: 10200332
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of fumonisin B1 on cell death in cultured cells: the significance of the elevated sphinganine.
Yu CH; Lee YM; Yun YP; Yoo HS
Arch Pharm Res; 2001 Apr; 24(2):136-43. PubMed ID: 11339633
[TBL] [Abstract][Full Text] [Related]
3. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.
Yoo HS; Norred WP; Showker J; Riley RT
Toxicol Appl Pharmacol; 1996 Jun; 138(2):211-8. PubMed ID: 8658522
[TBL] [Abstract][Full Text] [Related]
4. Fumonisin B(1) induces apoptosis in LLC-PK(1) renal epithelial cells via a sphinganine- and calmodulin-dependent pathway.
Kim MS; Lee DY; Wang T; Schroeder JJ
Toxicol Appl Pharmacol; 2001 Oct; 176(2):118-26. PubMed ID: 11601888
[TBL] [Abstract][Full Text] [Related]
5. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
Tsunoda M; Sharma RP; Riley RT
J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis in cultured human proximal tubule cells by fumonisins and fumonisin metabolites.
Seefelder W; Humpf HU; Schwerdt G; Freudinger R; Gekle M
Toxicol Appl Pharmacol; 2003 Oct; 192(2):146-53. PubMed ID: 14550748
[TBL] [Abstract][Full Text] [Related]
7. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies).
Natl Toxicol Program Tech Rep Ser; 2001 Dec; (496):1-352. PubMed ID: 11852482
[TBL] [Abstract][Full Text] [Related]
8. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
Merrill AH; van Echten G; Wang E; Sandhoff K
J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of sphingolipid synthesis modulate interferon (IFN)-gamma-induced intercellular adhesion molecule (ICAM)-1 and human leukocyte antigen (HLA)-DR expression on cultured normal human keratinocytes: possible involvement of ceramide in biologic action of IFN-gamma.
Wakita H; Nishimura K; Tokura Y; Furukawa F; Takigawa M
J Invest Dermatol; 1996 Sep; 107(3):336-42. PubMed ID: 8751967
[TBL] [Abstract][Full Text] [Related]
10. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
[TBL] [Abstract][Full Text] [Related]
11. Sphingoid bases and their phosphates: transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity.
Gopee NV; Sharma RP
Toxicology; 2003 May; 187(2-3):239-50. PubMed ID: 12699912
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases.
Schmelz EM; Dombrink-Kurtzman MA; Roberts PC; Kozutsumi Y; Kawasaki T; Merrill AH
Toxicol Appl Pharmacol; 1998 Feb; 148(2):252-60. PubMed ID: 9473533
[TBL] [Abstract][Full Text] [Related]
13. Tissue sphinganine as a biomarker of fumonisin-induced apoptosis.
Delongchamp RR; Young JF
Food Addit Contam; 2001 Mar; 18(3):255-61. PubMed ID: 11304034
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of sphingolipids: dihydroceramide and not sphinganine is desaturated by cultured cells.
Rother J; van Echten G; Schwarzmann G; Sandhoff K
Biochem Biophys Res Commun; 1992 Nov; 189(1):14-20. PubMed ID: 1449467
[TBL] [Abstract][Full Text] [Related]
15. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
He Q; Riley RT; Sharma RP
Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
[TBL] [Abstract][Full Text] [Related]
16. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs.
Riley RT; An NH; Showker JL; Yoo HS; Norred WP; Chamberlain WJ; Wang E; Merrill AH; Motelin G; Beasley VR
Toxicol Appl Pharmacol; 1993 Jan; 118(1):105-12. PubMed ID: 8430417
[TBL] [Abstract][Full Text] [Related]
17. Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis.
Desai K; Sullards MC; Allegood J; Wang E; Schmelz EM; Hartl M; Humpf HU; Liotta DC; Peng Q; Merrill AH
Biochim Biophys Acta; 2002 Dec; 1585(2-3):188-92. PubMed ID: 12531553
[TBL] [Abstract][Full Text] [Related]
18. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme.
Wang E; Ross PF; Wilson TM; Riley RT; Merrill AH
J Nutr; 1992 Aug; 122(8):1706-16. PubMed ID: 1640265
[TBL] [Abstract][Full Text] [Related]
19. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells.
Yoo HS; Norred WP; Wang E; Merrill AH; Riley RT
Toxicol Appl Pharmacol; 1992 May; 114(1):9-15. PubMed ID: 1585377
[TBL] [Abstract][Full Text] [Related]
20. Fumonisin B1 alters sphingolipid metabolism and disrupts the barrier function of endothelial cells in culture.
Ramasamy S; Wang E; Hennig B; Merrill AH
Toxicol Appl Pharmacol; 1995 Aug; 133(2):343-8. PubMed ID: 7645031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
